Capture more 340B savings. Fund more patient care.
Callara follows each prescription from the point of care to a completed, paid fill at your pharmacy, contract or in-house, so more of the savings your program earns come back to fund care.
Prescribers make every clinical decision. Callara shows coverage and patient cost, never a margin.
Tradjenta 5mglinagliptin · 30 ct
- 340B tier
- Preferred
- Patient pays
- $4 if plan pays
Example
James T. · Tradjenta 5mg
- Decision loggedAt the clinic · 9:42 AM
- Will CallOn the pharmacy shelf · not counted yet
- Completed, paidLeft with the patient · counted
Example
One loop, two buildings
Neither side alone can prove capture.
The decision is logged at the clinic. The fill event arrives from the pharmacy. Callara closes the loop between them.
At the clinic
At the pharmacy
Callara closes the loop
PioneerRx fill feed live today. Other pharmacy systems scoped at onboarding.
At the clinic
- 01Decision loggedA 340B search at the point of care.
- 02Provider viewTiers and patient cost. No entity economics.
At the pharmacy
- 03Fill eventThe pharmacy system sends the dispense.
- 04Completed, paidRegister status plus the claim outcome.
PioneerRx fill feed live today. Other pharmacy systems scoped at onboarding.
In your report
- 05Capture reportCaptured, leaked or unseen, fill by fill.
Callara closes the loop
Decision · what your providers see
Tiers and patient cost. Never entity margin.
Providers see each option in the drug class and what the patient pays. The economics stay with your program.
- Ranked within its class, on the dispensed presentation.
- Patient cost at the decision point, with plan caveats stated.
- No margin columns, no acquisition costs. The gate is server-side, applied by role, on by default.
PreferredStrong optionModerateCovered
| Option | 340B tier | Patient pays |
|---|---|---|
| Tradjentalinagliptin | Preferred | $4 if plan pays |
| Nesinaalogliptin | ||
| Januviasitagliptin |
Full class ranking in the platform
Example. Live results rank the dispensed NDC within its drug class.
Capture · what the report says
A fill counts once it’s completed and paid.
The bag reached the shelf. Not counted yet.
It left with the patient, and the claim paid. Counted.
- Captured
- The prescription reached a completed, paid 340B fill.
- Leaked
- An assistance-enrolled patient, so absence is provable, and the fill never completed here.
- Unseen
- Everyone else. They may have filled at another pharmacy, so they are excluded from the rate, and the report says so.
The Recommendations tab shows every logged decision and how it resolved. The Dispensing tab shows every 340B fill at the pharmacy, whether Callara was consulted or not.
| Patient · decision | Fill | Resolved |
|---|---|---|
| Robert M.Tradjenta 5mg | Completed, paid | CapturedCompleted, paid |
| Anita P.Januvia 100mg | Will Call | Not counted yetWill Call |
| Maria G.Nesina 25mg | Never completed here | LeakedNever completed here |
| Denise W.Tradjenta 5mg | Not seen here | UnseenNot seen here |
Rate basis · patients where absence can be proven. Unseen excluded.
Example
Why now
Jan 1, 2027. Part of your 340B discount becomes a rebate.
HRSA’s revised rebate pilot, for the Medicare-negotiated drugs.
- Aug 3Federal Register notice
- Aug 24manufacturer plans due
- Sept 24HRSA approval date
- Jan 1rebates begin
- +45 daysclaim-level data submitted
- +10 dayspaid or denied
340B has never been a receivable before. A receivable is only as good as the record behind it. Ours starts at the decision.
Callara does not file rebate claims. It keeps the record behind them, with the decision, the fill and the payment tied together.
Dates as set in the rebate pilot notice. Sources:
HRSA press release, July 31, 2026Federal Register notice, August 3, 2026
See how fully your program captures its 340B savings.
We’ll run the decision and the capture report against a program like yours. Priced flat, never a percentage of your savings.
